Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for this forum to get back on track.

<So the question still remains: Will TPL take the T3 to the end? Many posts have been made about the ENDGAME.>

Not sure what you mean by taking it to the end. The J2.5 settlement was not the end, but in time we knew what the settlement was and pps reacted accordingly. So the end, IMHO is the revenue line and eps in the qtrlys.

Opty

Share
New Message
Please login to post a reply